BIOHEART-B (02185) announced that on August 7, 2025, the company acquired the purchased award shares from the trustee at zero consideration, which were subsequently cancelled on the same date by the company's H-share registrar. The total number of purchased award shares bought back and cancelled represents approximately 0.21% of the company's total issued share capital before the completion of the buyback and cancellation of the purchased award shares. Immediately following the completion of the buyback and cancellation of the purchased award shares, the company's registered capital was also changed from RMB 244 million to RMB 243 million.